Strategies and developments in next generation small molecule therapeutics, by Dr Hans-Joachim Böhm
Dr Hans-Joachim Böhm, Global Chemistry Head, Ctr Manager for R&D Basel, Roche, Switzerland will be presenting on the above topic at Drug Discovery World Asia 2012, part of a series of conferences at 5th Annual BioPharma Asia Convention 2012.
Dr Böhm is Global Head of Chemistry at Roche and Center Manager for the Roche Pharma Research and Early Development Site Basel. Prior to this, Dr Böhm was President and Research Site Head of Roche Palo Alto from October 2006 to June 2008. Hans-Joachim Böhm also headed Non-clinical Development at Roche Basel from January 2005 until September 2006, the Discovery Chemistry Department from 2002 – 2004, the Discovery Technology Department from 2000-2001 and the Research Informatics Department in Basel. Before joining Roche in 1996,
Dr Böhm worked for BASF in Ludwigshafen as Computational Chemist from 1988-1996 and for Siemens in Munich in field of Microelectronics from 1985-1987. He obtained his Ph.D. in Theoretical Chemistry at the University of Karlsruhe in 1984.
Dr Böhm will be speaking on the following topics:
Strategies and developments in next generation small molecule therapeutics
1. Strategies to develop safe and efficacious next generation small molecule therapeutics
2. New approaches to target identification
3. New technologies for drug discovery
4. Creating an entrepreneurial organization with a focus on innovation